Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Breast-Conserving Surgery for Implants

By HospiMedica staff writers
Posted on 23 Oct 2005
A new study has found that breast-conserving treatment is a good option for women with early-stage breast cancer who have breast implants.

Past studies showed that delivering radiation to a breast with an implant in place causes significant problems in the implant, resulting in poor cosmetic results. More...
New techniques have changed this.

"Past research was based on a small sample of patients and older radiation techniques,” said lead author Rosalyn Morrell, M.D., Mayo Clinic (Rochester, MN, USA). "Therefore, we investigated a larger group of women treated with radiation using newer techniques that refuted the reports of poor cosmetic outcome among patients.”

Breast-conservation surgery allows women to keep their breast following cancer treatment. First, they have a lumpectomy to remove the cancer, which is followed by radiation therapy to kill any remaining cancer cells. This routine has been found to be just as effective as a mastectomy in treating the cancer and is preferred by many women. Today, more women are opting to have cosmetic breast implants. As they age, their risk of cancer increases, so some fraction of these women will develop breast cancer. These are the patients most interested in preserving their breasts and avoiding mastectomy.

In the study, researchers reviewed the records of 26 breast cancer patients with previously augmented breasts who were treated with a lumpectomy and radiation at the Mayo Clinic. All had their implants in place before the breast cancer diagnosis. Of these, 85% who were followed over a three-year period had favorable cosmetic results following radiation therapy. None suffered a relapse of cancer. The study's findings were presented at the annual meeting of the American Society for Therapeutic Radiology and Oncology in Denver (CO, USA) in October 2005.






Related Links:
Mayo Clinic

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.